Literature DB >> 9561092

MRX 501: a novel ultrasound contrast agent with therapeutic properties.

E C Unger1, T McCreery, R Sweitzer, G Vielhauer, G Wu, D Shen, D Yellowhair.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561092     DOI: 10.1016/s1076-6332(98)80119-0

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  7 in total

Review 1.  Microbubbles in ultrasound-triggered drug and gene delivery.

Authors:  Sophie Hernot; Alexander L Klibanov
Journal:  Adv Drug Deliv Rev       Date:  2008-04-03       Impact factor: 15.470

2.  Microbubble Compositions, Properties and Biomedical Applications.

Authors:  Shashank Sirsi; Mark Borden
Journal:  Bubble Sci Eng Technol       Date:  2009-11

3.  Intravascular ultrasound catheter to enhance microbubble-based drug delivery via acoustic radiation force.

Authors:  Joseph P Kilroy; Alexander L Klibanov; Brian R Wamhoff; John A Hossack
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2012-10       Impact factor: 2.725

4.  Vesicles tethered to microbubbles by hybridized DNA oligonucleotides: flow cytometry analysis of this new drug delivery vehicle design.

Authors:  Monica M Lozano; Cambrie D Starkel; Marjorie L Longo
Journal:  Langmuir       Date:  2010-06-01       Impact factor: 3.882

5.  Targeted multifunctional multimodal protein-shell microspheres as cancer imaging contrast agents.

Authors:  Renu John; Freddy T Nguyen; Kenneth J Kolbeck; Eric J Chaney; Marina Marjanovic; Kenneth S Suslick; Stephen A Boppart
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

Review 6.  Targeted renal therapies through microbubbles and ultrasound.

Authors:  Leo E Deelman; Anne-Emilie Declèves; Joshua J Rychak; Kumar Sharma
Journal:  Adv Drug Deliv Rev       Date:  2010-10-11       Impact factor: 15.470

Review 7.  Ultrasound in Radiology: From Anatomic, Functional, Molecular Imaging to Drug Delivery and Image-Guided Therapy.

Authors:  Alexander L Klibanov; John A Hossack
Journal:  Invest Radiol       Date:  2015-09       Impact factor: 6.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.